Pain Management Of Patients With Head And Neck Cancer In Palliative Care: A Literature Review Controle De Dor De Pacientes Com Câncer De Cabeça E Pescoço Em Cuidados Paliativos: Uma Revisão De Literatura
Main Article Content
Abstract
Patients with head and neck cancer (HNC) display limitations and functional impairments. Orofacial pain affects the majority of these patients and may be caused by various factors, both in soft and hard tissues. Patients with advanced stage HNC need to be assisted in a way that promotes quality of life for them and their relatives, as a form of palliative care, especially when the disease is no longer likely to be controlled. Pharmacological analgesia is the backbone of the treatment of cancer pain, but it can also be carried out through non-pharmacological therapies. This study aimed at reviewing the literature and seeking the different pathways to control orofacial pain in patients with HNC in palliative care. Searches in the PubMed and SciELO databases were performed with the words “(pain control) AND (palliative care) AND (head and neck cancer),” aiming to find papers published through the last ten years (2011-2021) and restricting them to clinical trials and randomized clinical trials. We found ten articles in the PubMed database and none in SciELO. After reading their titles and abstracts, we excluded five of them since they did not evaluate patients with HNC nor did they have the analgesic approach as a study objective; therefore, five papers were included in our review. Most studies have shown that analgesia in patients in palliative care affected by malignant head and neck injuries happens with opioids. In this review, we observed a few clinical trials, and further studies must be carried out to seek new ways to reduce symptoms and improve the quality of life of these patients.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
Revista Naval de Odontologia - 2022 - Volume 49 Número 245
6. Sampaio SG dos SM, Motta LB da, Caldas CP. Medicamentos e Controle de dor: Experiência de um Centro de Referência em Cuidados Paliativos no Brasil. Rev Bras Cancerol. 24 de outubro de 2019;65(2):e-13365. 7. Jales SMCP, Siqueira JTT. Papel do dentista em Cuidado Paliativo. Em: Manual de Cuidados Paliativos. Rio de Janeiro: Diagraphic; 2009. 8. Narayanan RS, Nair MK, Padmanabhan TK. Palliation of pain in advanced oral cancer. Headache. maio de 1988;28(4):258–9. 9. Merskey, H, Bogduk, N. Task force of taxonomy: classification of chronic pain. 2nd Edition. Seattle: IASP Press; 1994. 10. Medeiros e Silva S. MANEJO DA DOR NO PACIENTE ONCOLÓGICO. Em: Diretrizes Oncológicas 2. 2o ed São Paulo: Doctor Press Ed. Cientifica; 2019. p. 15–23. 11. Dalva Yukie Matsumoto. Cuidados Paliativos: conceito, fundamentos e princípios. Em: Manual de Cuidados Paliativos da ANCP. 1a ed. Rio de Janeiro: Diagraphic; 2009. 12. Leticia Meda Vendrusculo-Fangel. CUIDADOS PALIATIVOS: CONCEITOS, FUNDAMENTOS E PRINCÍPIOS. Em: Diretrizes Oncológicas 2. São Paulo: Doctorpress; 2019. 13. Vargas-Schaffer G. Is the WHO analgesic ladder still valid? Twenty-four years of experience. Can Fam Physician Med Fam Can. junho de 2010;56(6):514–7, e202-205. 14. WHO | National cancer control programmes: [Internet]. WHO. World Health Organization; [citado 7 de julho de 2021]. Disponível em: https://www.who.int/ reproductivehealth/publications/cancers/9241545577/en/ 15. Rangel O, Telles C. Tratamento da dor oncológica em cuidados paliativos. Rev Hosp Univ Pedro Ernesto [Internet]. 2012;11(2). Disponível em: https://www.e-publicacoes.uerj. br/index.php/revistahupe/article/view/8928 16. Cardoso MG de M. Controle da Dor. Em: Manual de cuidados paliativos. Rio de Janeiro: Diagraphic; 2009. 17. Kashyap K, Singh V, Mishra S, Dwivedi SN, Bhatnagar S. The Efficacy of Scrambler Therapy for the Management of Head, Neck and Thoracic Cancer Pain: A Randomized Controlled Trial. Pain Physician. setembro de 2020;23(5):495–506. 18. Haumann J, Geurts JW, van Kuijk SMJ, Kremer B, Joosten EA, van den Beuken-van Everdingen MHJ. Methadone is superior to fentanyl in treating neuropathic pain in patients with head-and-neck cancer. Eur J Cancer Oxf Engl 1990. setembro de 2016;65:121–9. 19. Haumann J, van Kuijk SMJ, Geurts JW, Hoebers FJP, Kremer B, Joosten EA, et al. Methadone versus Fentanyl in Patients with Radiation-Induced Nociceptive Pain with Head and Neck Cancer: A Randomized Controlled Noninferiority Trial. Pain Pract Off J World Inst Pain. março de 2018;18(3):331–40. 20. Williams JE, Peacock J, Gubbay AN, Kuo PY, Ellard R, Gupta R, et al. Routine screening for pain combined with a pain treatment protocol in head and neck cancer: a randomised controlled trial. Br J Anaesth. outubro de 2015;115(4):621–8. 21. Farina E, Capuccini J, Macchia G, Caravatta L, Nguyen NP, Cammelli S, et al. Short course accelerated radiation therapy (SHARON) in palliative treatment of advanced solid cancer in older patients: A pooled analysis. J Geriatr Oncol. julho de 2018;9(4):359–61. 22. Siqueira JTT, Jales S, Vilarim RCB. Dor orofacial e cuidados paliativos orais em pacientes com câncer. Revista Onco. junho de 2013;Ano 3(n° 17):25–8.
23. Adriana Thomaz. Dor oncológica: conceitualização e tratamento farmacológico. Revista Onco. setembro de 2010;Ano 1(n° 1):24–9. 24. Ventafridda V, Tamburini M, Caraceni A, De Conno F, Naldi F. A validation study of the WHO method for cancer pain relief. Cancer. 15 de fevereiro de 1987;59(4):850–6. 25. Mercadante S, Fulfaro F. World Health Organization guidelines for cancer pain: a reappraisal. Ann Oncol Off J Eur Soc Med Oncol. maio de 2005;16 Suppl 4:iv132-135. 26. Deandrea S, Montanari M, Moja L, Apolone G. Prevalence of undertreatment in cancer pain. A review of published literature. Ann Oncol Off J Eur Soc Med Oncol. dezembro de 2008;19(12):1985–91. 27. Cipta AM, Pietras CJ, Weiss TE, Strouse TB. Cancerrelated pain management in clinical oncology. J Community Support Oncol. outubro de 2015;13(10):347–55. 28. Haozous EA, Knobf MT. “All my tears were gone”: suffering and cancer pain in Southwest American Indians. J Pain Symptom Manage. junho de 2013;45(6):1050–60. 29. Ebert B, Andersen S, Krogsgaard-Larsen P. Ketobemidone, methadone and pethidine are non-competitive N-methyl-daspartate (NMDA) antagonists in the rat cortex and spinal cord. Neurosci Lett. 10 de março de 1995;187(3):165–8. 30. Coyne PJ, Wan W, Dodson P, Swainey C, Smith TJ. A trial of Scrambler therapy in the treatment of cancer pain syndromes and chronic chemotherapy-induced peripheral neuropathy. J Pain Palliat Care Pharmacother. dezembro de 2013;27(4):359–64. 31. Marineo G. Inside the Scrambler Therapy, a Noninvasive Treatment of Chronic Neuropathic and Cancer Pain: From the Gate Control Theory to the Active Principle of Information. Integr Cancer Ther. dezembro de 2019;18:1534735419845143. 32. Marineo G, Iorno V, Gandini C, Moschini V, Smith TJ. Scrambler therapy may relieve chronic neuropathic pain more effectively than guideline-based drug management: results of a pilot, randomized, controlled trial. J Pain Symptom Manage. janeiro de 2012;43(1):87–95. 33. Chwistek M. Recent advances in understanding and managing cancer pain. F1000Research. 20 de junho de 2017;6:945. 34. Gillison TL, Chatta GS. Cancer chemotherapy in the elderly patient. Oncol Williston Park N. janeiro de 2010;24(1):76–85. 35. Smith GL, Smith BD. Radiation treatment in older patients: a framework for clinical decision making. J Clin Oncol Off J Am Soc Clin Oncol. 20 de agosto de 2014;32(24):2669–78. 36. Gordon DB, Dahl JL, Miaskowski C, McCarberg B, Todd KH, Paice JA, et al. American pain society recommendations for improving the quality of acute and cancer pain management: American Pain Society Quality of Care Task Force. Arch Intern Med. 25 de julho de 2005;165(14):1574–80. 37. Miaskowski C. The next step to improving cancer pain management. Pain Manag Nurs Off J Am Soc Pain Manag Nurses. março de 2005;6(1):1–2. 38. Oldenmenger WH, Sillevis Smitt PAE, van Montfort CAGM, de Raaf PJ, van der Rijt CCD. A combined pain consultation and pain education program decreases average and current pain and decreases interference in daily life by pain in oncology outpatients: a randomized controlled trial. Pain. novembro de 2011;152(11):2632–9. 39. Williams JE, Yen JTC, Parker G, Chapman S, Kandikattu S, Barbachano Y. Prevalence of pain in head and neck cancer out-patients. J Laryngol Otol. julho de 2010;124(7):767–73.